111 related articles for article (PubMed ID: 7586587)
1. Sensitivity and specificity of a new ELISA method for determination of chromogranin A in the diagnosis of pheochromocytoma and neuroblastoma.
Boomsma F; Bhaggoe UM; Man in 't Veld AJ; Schalekamp MA
Clin Chim Acta; 1995 Jul; 239(1):57-63. PubMed ID: 7586587
[TBL] [Abstract][Full Text] [Related]
2. Chromogranin A storage and secretion: sensitivity and specificity for the diagnosis of pheochromocytoma.
Hsiao RJ; Parmer RJ; Takiyyuddin MA; O'Connor DT
Medicine (Baltimore); 1991 Jan; 70(1):33-45. PubMed ID: 1988765
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic specificity of serum chromogranin-A for pheochromocytoma in patients with renal dysfunction.
Canale MP; Bravo EL
J Clin Endocrinol Metab; 1994 May; 78(5):1139-44. PubMed ID: 8175970
[TBL] [Abstract][Full Text] [Related]
4. Malignant pheochromocytoma. Chromaffin granule transmitters and response to treatment.
Rao F; Keiser HR; O'Connor DT
Hypertension; 2000 Dec; 36(6):1045-52. PubMed ID: 11116123
[TBL] [Abstract][Full Text] [Related]
5. [Chromogranin A, chromogranin B, chromogranin C].
Takekoshi K
Nihon Rinsho; 2005 Aug; 63 Suppl 8():407-10. PubMed ID: 16149541
[No Abstract] [Full Text] [Related]
6. A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours.
Bernini GP; Moretti A; Ferdeghini M; Ricci S; Letizia C; D'Erasmo E; Argenio GF; Salvetti A
Br J Cancer; 2001 Mar; 84(5):636-42. PubMed ID: 11237384
[TBL] [Abstract][Full Text] [Related]
7. Chromogranin A in familial pheochromocytoma: diagnostic screening value, prediction of tumor mass, and post-resection kinetics indicating two-compartment distribution.
Hsiao RJ; Neumann HP; Parmer RJ; Barbosa JA; O'Connor DT
Am J Med; 1990 Jun; 88(6):607-13. PubMed ID: 2189303
[TBL] [Abstract][Full Text] [Related]
8. Chromogranin A and chromogranin B are sensitive circulating markers for phaeochromocytoma.
Stridsberg M; Husebye ES
Eur J Endocrinol; 1997 Jan; 136(1):67-73. PubMed ID: 9037129
[TBL] [Abstract][Full Text] [Related]
9. Plasma and urinary metanephrines determined by an enzyme immunoassay, but not serum chromogranin A for the diagnosis of pheochromocytoma in patients with adrenal mass.
Unger N; Hinrichs J; Deutschbein T; Schmidt H; Walz MK; Mann K; Petersenn S
Exp Clin Endocrinol Diabetes; 2012 Sep; 120(8):494-500. PubMed ID: 22696168
[TBL] [Abstract][Full Text] [Related]
10. Plasma chromogranin A in pheochromocytoma, primary hyperparathyroidism and pituitary adenoma in comparison with catecholamine, parathyroid hormone and pituitary hormones.
Kimura N; Miura W; Noshiro T; Mizunashi K; Hanew K; Shimizu K; Watanabe T; Shibukawa S; Sohn HE; Abe K; Miura Y; Nagura H
Endocr J; 1997 Apr; 44(2):319-27. PubMed ID: 9228469
[TBL] [Abstract][Full Text] [Related]
11. Radioimmunoassay of chromogranin A in plasma as a measure of exocytotic sympathoadrenal activity in normal subjects and patients with pheochromocytoma.
O'Connor DT; Bernstein KN
N Engl J Med; 1984 Sep; 311(12):764-70. PubMed ID: 6472366
[TBL] [Abstract][Full Text] [Related]
12. Application of region-specific immunoassay for human chromogranin A: substantial clue for detection and measurement of chromogranin A in human plasma.
Yanaihara H; Hata M; Nishikawa Y; Hoshino M; Yanaihara N; Murai M
Regul Pept; 1999 Mar; 80(1-2):83-90. PubMed ID: 10235638
[TBL] [Abstract][Full Text] [Related]
13. Chromogranin A in children with neuroblastoma. Serum concentration parallels disease stage and predicts survival.
Hsiao RJ; Seeger RC; Yu AL; O'Connor DT
J Clin Invest; 1990 May; 85(5):1555-9. PubMed ID: 2332506
[TBL] [Abstract][Full Text] [Related]
14. Plasma chromogranin A as a marker of sympathochromaffin activity in humans.
Cryer PE; Wortsman J; Shah SD; Nowak RM; Deftos LJ
Am J Physiol; 1991 Feb; 260(2 Pt 1):E243-6. PubMed ID: 1996627
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significant of serum chromogranin A levels for diagnosing pheochromocytoma in hypertensive patients].
Biausque F; Jaboureck O; Devos P; D'Herbomez M; Hainaut P; Carré A; Mounier-Vehier C
Arch Mal Coeur Vaiss; 2003; 96(7-8):780-3. PubMed ID: 12945223
[TBL] [Abstract][Full Text] [Related]
16. [The sympathetic nervous system activity estimated on serum concentration of chromogranin A in patients with the chronic heart failure].
Rubinsztajn R
Pol Arch Med Wewn; 2001 Mar; 105(3):217-24. PubMed ID: 11680266
[TBL] [Abstract][Full Text] [Related]
17. Development of a microplate assay for serum chromogranin A (CgA): establishment of normal reference values and detection of elevated CgA in malignant diseases.
Wu TL; Chang CP; Tsao KC; Sun CF; Wu JT
J Clin Lab Anal; 1999; 13(6):312-9. PubMed ID: 10633301
[TBL] [Abstract][Full Text] [Related]
18. Chromogranin A assay and (131)I-MIBG scintigraphy for diagnosis and follow-up of pheochromocytoma.
d'Herbomez M; Gouze V; Huglo D; Nocaudie M; Pattou F; Proye C; Wémeau JL; Marchandise X
J Nucl Med; 2001 Jul; 42(7):993-7. PubMed ID: 11438617
[TBL] [Abstract][Full Text] [Related]
19. Rapid radioimmunoassay of circulating chromogranin A: in vitro stability, exploration of the neuroendocrine character of neoplasia, and assessment of the effects of organ failure.
O'Connor DT; Pandlan MR; Carlton E; Cervenka JH; Hslao RJ
Clin Chem; 1989 Aug; 35(8):1631-7. PubMed ID: 2547534
[TBL] [Abstract][Full Text] [Related]
20. Plasma chromogranin A. Initial studies in human hypertension.
O'Connor DT
Hypertension; 1985; 7(3 Pt 2):I76-9. PubMed ID: 3997234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
